The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CBLL · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | ACAD | IMAX | CBLL | BVS |
|---|---|---|---|---|
| Moat Score (0–100) | 61 (highest) | 61 (highest) | 61 (highest) | 61 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 80 (highest) | 80 (highest) | 70 | 74 |
| Pricing power | 98 | 66 | 100 (highest) | 97 |
| Returns on capital | 4 | 35 (highest) | — | 7 |
| Balance-sheet safety | 100 (highest) | 51 | 28 | 67 |
| Capital allocation | 24 | 74 (highest) | 47 | 58 |
| No price data | 167% above value if growth stopped today (largest discount to value if growth stopped today) | No price data | 489% above value if growth stopped today | |
| Market cap | $4.2B | $2.3B | $634M | $813M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |